Rick E. Winningham, CHIEF EXECUTIVE OFFICER at Theravance Biopharma, Inc. (TBPH), sold 59,000 shares at $11.19 ($560K) on 2022-12-14, disclosed to the SEC on 2022-12-16.
Open-market sale of $560k TBPH by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 9,000 | $0 | 0.0% |
| 2 | $11.19 | 50,000 | $560K | 100.0% |
| Total | $9.48 avg | 59,000 | $560K | 100% |
| Filing → |
| JAZZ | SELL | 2023-08-15 | $343K | — | Filing → |
| JAZZ | SELL | 2022-08-09 | $332K | — | Filing → |
| JAZZ | SELL | 2021-08-10 | $386K | — | Filing → |